» Articles » PMID: 30095897

Development of Multifunctional Molecules As Potential Therapeutic Candidates for Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis in the Last Decade

Overview
Journal Chem Rev
Specialty Chemistry
Date 2018 Aug 11
PMID 30095897
Citations 144
Authors
Affiliations
Soon will be listed here.
Abstract

Neurodegenerative diseases pose a substantial socioeconomic burden on society. Unfortunately, the aging world population and lack of effective cures foreshadow a negative outlook. Although a large amount of research has been dedicated to elucidating the pathologies of neurodegenerative diseases, their principal causes remain elusive. Metal ion dyshomeostasis, proteopathy, oxidative stress, and neurotransmitter deficiencies are pathological features shared across multiple neurodegenerative disorders. In addition, these factors are proposed to be interrelated upon disease progression. Thus, the development of multifunctional compounds capable of simultaneously interacting with several pathological components has been suggested as a solution to undertake the complex pathologies of neurodegenerative diseases. In this review, we outline and discuss possible therapeutic targets in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis and molecules, previously designed or discovered as potential drug candidates for these disorders with emphasis on multifunctionality. In addition, underrepresented areas of research are discussed to indicate new directions.

Citing Articles

Energy metabolism in health and diseases.

Liu H, Wang S, Wang J, Guo X, Song Y, Fu K Signal Transduct Target Ther. 2025; 10(1):69.

PMID: 39966374 PMC: 11836267. DOI: 10.1038/s41392-025-02141-x.


A stacking classifier for distinguishing stages of Alzheimer's disease from a subnetwork perspective.

Li G, Chen B, Sun W, Liu Z Cogn Neurodyn. 2025; 19(1):38.

PMID: 39926335 PMC: 11799466. DOI: 10.1007/s11571-025-10221-5.


Zn(ii)-driven impact of monomeric transthyretin on amyloid-β amyloidogenesis.

Yi Y, Kim B, Kim M, Ko Y, Kim J, Lim M Chem Sci. 2025; 16(10):4366-4373.

PMID: 39911331 PMC: 11793109. DOI: 10.1039/d4sc08771b.


Peptide-based amyloid-beta aggregation inhibitors.

Sehra N, Parmar R, Jain R RSC Med Chem. 2025; .

PMID: 39882170 PMC: 11773382. DOI: 10.1039/d4md00729h.


Plasma Endothelin-1 Levels: Non-Predictors of Alzheimer's Disease Reveal Age Correlation in African American Women.

Zagol-Ikapitte I, Tabatabai M, Wilus D, Alcendor D J Clin Med. 2025; 14(2).

PMID: 39860641 PMC: 11766246. DOI: 10.3390/jcm14020635.